TrialCritical care (London, England)2014

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Georg Fuernau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.